Journal of Pathology and Translational Medicine10.4132/jptm.2019.11.122020542146-153Double cocktail immunostains with high molecular weight cytokeratin and GATA-3: useful stain to discriminate in situ involvement of prostatic ducts or acini from stromal invasion by urothelial carcinoma in the prostateJunghye Lee, Youngeun Yoo, Sanghui Park, Min-Sun Cho, Sun Hee Sung, Jae Y. Ro,,
Pathology10.1097/pat.0b013e3283511c732012443199-203Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and aciniElizabeth C. Chastain, Irma V. Oliva, Adeboye O. Osunkoya,
Journal of Urology10.1016/j.juro.2014.02.190220141914SMP65-05 TRANSURETHRAL BIOPSY OF THE PROSTATIC URETHRA FREQUENTLY DETECTS CARCINOMA IN-SITU AND INVASIVE UROTHELIAL CARCINOMA ARISING FROM THE PROSTATIC URETHRA AND DUCTS/ACINIFriedrich-Carl von Rundstedt, Seth P. Lerner, Thomas Wheeler, Gilad Amiel, Luan D. Trong, Steven Shen,
European Urology Supplements10.1016/s1569-9056(14)60888-52014131e902902 Transurethral biopsy of the prostatic urethra frequently detects carcinoma in-situ and invasive urothelial carcinoma arising from the prostatic urethra and ducts/aciniF.C. Von Rundstedt, S.P. Lerner, G. Amiel, T.M. Wheeler, L.D. Truong, S.S. Shen,
The Prostate10.1002/pros.101962003544290-298Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasiaTuomas Mirtti, Kalle Alanen, Markku Kallajoki, Ari Rinne, Karl-Ove Söderström,
Pathology10.1016/j.pathol.2018.07.0062018507787-789Prostatic adenocarcinoma with aberrant diffuse expression of high molecular weight cytokeratinMeenal Sharma, Hiroshi Miyamoto,
International Journal of Urology10.1111/j.1442-2042.2006.01569.x200613111448-1450Urothelial carcinoma (clear cell variant) diagnosed with useful immunohistochemistry stainRYO YAMASHITA, RAIZOU YAMAGUCHI, KEIJI YUEN, MASASHI NIWAKAWA, KENICHI TOBISU
Human Pathology10.1016/j.humpath.2010.06.013201142151-56Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome?Irma V. Oliva, Stacey L. Smith, Zhengjia Chen, Adeboye O. Osunkoya,
Diagnostic Pathology: Cytopathology10.1016/b978-0-323-54763-5.50091-x2018242-243High-Grade Urothelial Dysplasia/Carcinoma/Carcinoma In Situ,
Diagnostic Pathology10.1186/s13000-020-00984-22020151CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive AtypiaDaniel J. Neal, Mahul B. Amin, Steven C. Smith,,